Introduction
Protein kinase C (PKC)' consists o 'a family of lipid-dependent serine/threonine kinases that are involved in regulating cell growth and differentiation in many organs, including the colon ( 1, 2) . Molecular cloning analysis has demonstrated that protein kinase C constitutes a family of at least 10 isozymes, including Ca2+-dependent (a, /,3I, and y) and Ca2+-independent or novel isoforms (6, e, w7, X, 0, and 4) (3, 4) . Although the PKC isozymes are homologous, sharing highly conserved domains, they differ in tissue expression, subcellular distribution, substrate specificity, and activating cofactor requirements, suggesting they have different functions (3, 5) . In this regard, Craven and DeRubertis (6) have recently demonstrated that the normal rat colon possesses PKC-a but not -,6 or -y.
In recent years the possibility of using dietary anticarcinogens as a strategy to prevent colon cancer has also been recognized (7) . One such potential colonic anticarcinogen, vitamin D3, and particularly its major biologically active metabolite, 1,25 (OH)2D3, has received increased attention in this regard. In addition to its well-established role in regulating mineral homeostasis, 1,25 (OH )2D3 has been shown to inhibit proliferation and induce differentiation in a number of normal and transformed cells (8) , including cells of the large intestine (9) . Other studies, using experimental models of colon cancer, have demonstrated that alterations in the vitamin D status of rats can influence the colonic malignant transformation process in this organ (10) (11) (12) .
During the past several years, in an attempt to further elucidate the roles of vitamin D in the physiologic regulation and pathophysiologic derangements of important cellular processes in the colon, our laboratory has studied the effects of 1,25 (OH)2D3 and other metabolites of vitamin D3 in rat colonic epithelial cells and in Caco-2 cells, a human colon cancerderived cell line. We have demonstrated that 1,25 (OH )2D3 rapidly (seconds-minutes) stimulated membrane polyphosphoinositide hydrolysis, increased intracellular calcium, and translo-cated PKC from the soluble to the particulate fraction in both rat colonic epithelia (13) and Caco-2 cells (14, 15) . Furthermore, we have described 1,25(OH)2D3-induced alterations in cellular proliferation and Na + -H + exchange in these cells ( 13, 14, 16) . Moreover, all these secosteroid-initiated events were lost in colonocytes prepared from vitamin D-deficient animals and partially restored by the in vivo repletion of 1,25(OH)2D3 (16) . These derangements accompanying D deficiency are of particular interest since, as noted above, vitamin D status can influence the development of experimental colon cancer (11, 12) .
While a number of studies have demonstrated phorbol ester-(17-19) or 1,25(OH)2D3-induced (13, 20) important events in normal or transformed colonocytes in association with PKC activation, the specific isoforms of PKC activated by these agents in these cells have not been established. In addition, an analysis of the Ca2+-independent isoforms of PKC in the normal rat colon has not been reported. In the present experiments, we have further characterized the PKC isoforms expressed in rat colonocytes and investigated the effects of 12-O-tetradecanoyl phorbol 13-acetate (TPA), as well as 1,25 (OH)2D3, on these isoforms. We have also examined the effect of vitamin D status on the expression and distribution of these isoforms and their responsiveness to acute treatment with 1, 25 ( 16) . Serum 25(OH)D3 and 1,25(OH)2D3 levels were assayed as previously described by our laboratory (13, 16 ). For the experiments described below, animals weighing 250-300 g in all three groups were fasted overnight except for water ad lib. On the day of the experiment, animals were killed, their colons were removed, and colonocytes were harvested using a technique that combined chelation of divalent cations with mild mechanical dissociation as previously described (13) . For each experiment, isolated colonocytes were pooled from three rat colons, collected by centrifugation at 500 g, and resuspended in KRB (pH 7.4) containing 1.2 mM CaCl2 and 180 mg% glucose (KRBG). Trypan blue exclusion in 2 90% of cells was observed for at least 75 min after isolation.
Detection of PKC isoforms by Western blotting in rat colonocytes. Isoform-specific antibodies were used to identify PKC isoforms present in isolated rat colonocytes. The monoclonal antibodies, PKC-a and PKC-/l, were prepared using as immunogens PKC-a and -,3 purified from rabbit brain cytosol. The antibodies reacted with rat PKC-a and -,B, respectively, as identified by Western blotting of rat brain. The polyclonal antipeptide antibodies to PKC-y, -6, -e, and -; were prepared from peptides with sequences deduced from isoform-specific rat brain cDNAs. Each of these antipeptide antibodies reacted in an isoformspecific manner with the respective rat PKC isoforms as identified by Western blotting of rat brain and elimination of immunoreactivity by preincubating the antibodies with the isoform-specific peptide used as immunogen.
To identify the PKC isoforms present in rat colonocytes and examine changes in their subcellular distributions in response to phorbol esters or 1,25(OH)2D3, isolated colonocytes ( 107 cells/ml) were incubated at 37°C in 2 ml of KRBG with the indicated agent or vehicle (ethanol, final concentration < 0.05%). In the case of 1,25 (OH)2D3, a concentration of 10 nM was chosen, as we have previously demonstrated significant activation of PKC in rat colonocytes at this concentration (13) . At the indicated times the cells were rapidly chilled to 4°C by the addition of 10 vol of ice-cold KRBG and collected by centrifugation. Cells were disrupted by sonication on ice in 0.8 ml homogenization buffer containing 20 mM Tris-HC1, pH 7.5, 0.5 mM EGTA, 2 mM EDTA, 0.2 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride, 0.5 mM benzamidine, 5 mM 2-mercaptoethanol, and 10 mg/l leupeptin. After a low speed centrifugation, the supernatant was separated into soluble and particulate fractions by centrifugation at 100,000 g for 60 min.
Aliquots of the soluble and particulate fractions were boiled in Laemmli SDS-containing buffer (21 ) , and proteins were measured (22) . Isoformspecific PKC expression was quantified as previously described (15 homogenates from vitamin D-sufficient animals.
MARCKS immunoprecipitation and back-phosphorylation with exogenous PKC. Colonocytes were prepared as described above and aliquots (1 ml, 107 cells/ml) incubated at 37°C with ethanol alone, (control, final concentration of ethanol 0.05%), or with 10 nM 1,25 (OH)2D3, or 300 nM TPA. At the indicated times, cells were lysed by boiling in an SDS-containing buffer, and MARCKS was immunoprecipitated (400 jig protein incubated for 12 h at 4°C with 10 Al of polyclonal rabbit antibodies) as previously described (23) . Immunoprecipitated MARCKS was back-phosphorylated for 30 min at 30°C as previously described (24) 6 , E, and 4 isoforms. We were, however, unable to detect PKC-4i or -y, despite partial PKC purification by DEAE chromatography of the 100,000-g soluble and Triton X-100-extracted particulate fractions (13), which were then probed for these isoforms by Western blotting. Under basal conditions, PKC-a and -; were predominantly soluble, with -70% found in the soluble fraction. In contrast, PKC-6 and -E were largely particulate associated ( Fig. 1) . PKC-a, -6, and -e redistribute in response to acute treatment with TPA. To examine the effects of phorbol esters on PKC isoforms in vitamin D-sufficient rat colonocytes, we investigated the time-dependent changes in PKC isoform distribution with TPA treatment. TPA (300 nM) caused translocations of soluble PKC-a, -6, and -E to the particulate fraction with no change in total isoform-specific PKC expression (Fig. 1) . For each of these isoforms the redistribution was significant within 10 min, and by 30 min the particulate fraction of PKC-a, -6, and -e had increased from 29, 63, and 86% to 71, 96, and 100%, respectively (Fig. 1) . PKC-4, in contrast, did not redistribute in response to TPA (Fig. 1) . The effect of TPA was concentration dependent, with 300 and 1,000 nM, but not 10 or 100 nM, causing significant increases in the particulate associations of PKC-a, -6, and -e (data not shown). The higher concentrations of TPA (300-1,000 nM) required to translocate these PKC isoforms in colonocytes is consistent with the previously reported greater doses of phorbol esters necessary to cause physiological responses in intestinal-derived cells (26) .
Vitamin D status modulates PKC isoform distribution, but not expression. In previous studies we have demonstrated that vitamin D deficiency abrogates a number of acute effects of 1,25 (OH)2D3 that occurred in response to this secosteroid in vitamin D-sufficient rat colonocytes (16) . It was, therefore, of interest to examine the effect of vitamin D status on PKC isoform expression and distribution. In agreement with prior studies from our laboratory, animals raised on vitamin D-sufficient or vitamin D-deficient diets were found to have comparable body weights (13, 16) . Moreover, 1,25 (OH)2D3 repletion was not associated with any changes in body weight (data not shown). Serum 25 (OH) D3 levels were, however, almost undetectable in the vitamin D-deficient group (< 5 ng/ml), and serum 1,25(OH)2D3 levels (22+4 pg/ml, n = 6) were significantly lower, compared to vitamin D-sufficient (96±13 pg/ml, n = 6, P < 0.05) or 1,25(OH)2D3-repleted rats (101+17 pg/ ml, n = 6, P < 0.05).
Neither the qualitative nor the quantitative expression of colonic PKC isoforms was altered by vitamin D deficiency or vitamin D repletion (data not shown). Vitamin D deficiency did, however, cause a significant redistribution (P < 0.005) of PKC-a and -4 from the soluble to particulate fraction (Fig.  2) . In contrast, vitamin D deficiency was accompanied by a significant translocation (P < 0.05) of PKC-6 from the particulate to soluble fraction ( viously described for MARCKS (24) . In a back-phosphorylation assay, agonist pretreatment, which inhibits subsequent substrate phosphorylation by an exogenous kinase, is interpreted to reflect agonist-stimulated phosphorylation of the substrate in intact cells with unlabeled phosphate. Isolated colonocytes were treated with vehicle (ethanol, 0.05% final concentration), 300 nM TPA, or 10 nM 1,25(OH)2D3 for the indicated times, reactions were stopped, and MARCKS was isolated by immunoprecipitation as described in Methods. After back-phosphorylation, MARCKS was resolved by SDS-PAGE or two-dimensional gel electrophoresis (25, 27) . The 32P-labeled immunoprecipitate in these back-phosphorylation experiments was indeed colonic MARCKS as assessed by four criteria: (a) immunoprecipitation with MARCKS-specific antisera (23); (b) ability to serve as a PKC substrate (27) ; (c) Mr 82,000 (27) ; and (d) acidic pI, 4.3 (27) . In three independent experiments, pretreatment with either TPA, a known activator of PKC, or 1,25 (OH)2D3 inhibited PKC back-phosphorylation of MARCKS immunoprecipitated from rat colonocytes. Treatment with 300 nM TPA for 5 min caused a 68.7±8.6% inhibition (P < 0.005), compared with vehicle-treated controls (Fig. 4) . Treatment of intact colonocytes with 10 nM 1,25 (OH)2D3 caused a time-dependent decrease in MARCKS back-phosphorylation that was significant by 90 s and persisted for at least 180 s (Fig. 5) . By 180 s, pretreatment with 1,25(OH)2D3 caused a 56±10% inhibition in MARCKS back-phosphorylation (Figs. 4 and 5) .
Discussion
The present studies have demonstrated for the first time that rat colonocytes express the Ca2+-independent PKC isoforms 6, E, and 4. Our studies confirm as well the earlier findings that, of the Ca2+-dependent PKC isoforms, only PKC-a is expressed (6) . Acute treatment of rat colonocytes with TPA increased the particulate association of PKC-a, -6, and -e for at least 30 min. In contrast, PKC-1 did not redistribute with TPA. The unresponsiveness of PKC-t to TPA treatment may reflect primary structural features in the C1 domain, the phorbol ester binding region (28) . Previous studies have shown that phorbol esters, presumably through PKC activation, alter several important processes in normal rat colonic epithelium, including Na+ and Cl-transport (17) and particulate guanylate cyclase activity (18) . Based on our present findings, PKC-a, -6, and/ or -E would appear to be involved in these phorbol ester-induced events. Previous studies from our laboratory have demonstrated that there is a redistribution of PKC biochemical activity from the soluble to the particulate fraction in colonocytes obtained from vitamin D-deficient rats, but no change in total activity (16) . In the present studies we have confirmed these observations, noting that, for each of the isoforms, total expression is unchanged in colonocytes from D-deficient rats. We have found, however, isoform-specific redistributions, with predominantly soluble isoforms moving to the particulate fraction and largely particulate-associated isoforms increasing their soluble distribution in D-deficiency. In addition to the effect of vitamin D status on basal PKC distribution, vitamin D status has been found to (30) . PKC translocation to the membrane is not, however, necessarily required for activation (31) . To further confirm that 1,25(OH)2D3 activated PKC, we therefore examined the effect of pretreatment of intact colonocytes with this secosteroid on the back-phosphorylation of MARCKS, a major substrate of PKC (27, 32) . Phosphorylation of MARCKS is widely accepted as a useful indicator of PKC activation in intact cells (23, 27) , although recent studies indicate that it serves as a substrate for proline-directed protein kinases such as microtubule-associated protein kinases and Cdk5 as well (33) . Inhibition of exogenous PKC back-phosphorylation of MARCKS should be a reliable indicator of MARCKS phosphorylation by endogenous PKC, as the phosphorylation sites of MARCKS by the endogenous or exogenous kinase appear to be identical (27 (34) .
MARCKS is an actin-cross-linking and calmodulin-binding protein that redistributes from the plasma membrane to the cytoplasm after phosphorylation by PKC (35, 36) , and it may be involved in the 1,25 (OH)2D3-induced morphologic changes previously described by our laboratory in Caco-2 cells (9). It is tempting to speculate that one or more of the events caused by colonocyte stimulation by 1,25 (OH)2D3, such as alterations in Na+ -H exchange ( 16) , changes in calcium entry across the plasma membrane (13) , and/or effects on cellular proliferation (13), may be regulated by calcium-dependent changes in MARCKS phosphorylation and/or calmodulin binding that mediate changes in the cytoskeleton. In this regard, we have previously shown that Na +-H+ exchange in Caco-2 cells is regulated by calcium and calmodulin (14) . MARCKS could, therefore, mediate calcium-sensitive reversible changes in actin assembly to regulate this exchange process.
The physiologic roles of specific PKC isoforms remain poorly defined. In the case of PKC-a, this isoform is ubiquitous, suggesting an essential role in the physiology of all cells (5) . PKC-a has been implicated in a number of cellular functions (15, 37, 38) , including our recent demonstration in Caco-2 cells that PKC-a, activated by 1,25 (OH)2D3, limited the secosteroidstimulated increase in free intracellular calcium (15) and activated particulate guanylate cyclase (38) . Less is known regarding the regulation and functions of the Ca2+-independent PKC isoforms 6, E, and 4, but, like the better-characterized classical isoforms, their effects are cell specific. We have recently demonstrated that PKC-4, an atypical member of the PKC family of isozymes implicated in regulating gene expression induced by growth factors and hormones (39, 40) , is constitutively expressed in the nucleus of Caco-2 cells (41) .
In 
